We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAPR icon
9926
Capricor Therapeutics
CAPR
$236M
$126K ﹤0.01%
36,703
+1,256
+4% +$5.45K
CLGN icon
9927
CollPlant Biotechnologies
CLGN
$5.7M
$126K ﹤0.01%
11,937
+971
+9% +$7.84K
DHC
9928
CALL
Diversified Healthcare Trust
DHC
$2.18B
$126K ﹤0.01%
30,500
+4,700
+18% +$18.5K
PBPB
9929
PUT
DELISTED
Potbelly
PBPB
$126K ﹤0.01%
+28,600
New +$121K
TLYS icon
9930
CALL
Tilly's
TLYS
$130M
$126K ﹤0.01%
+15,400
New +$116K
VIA
9931
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$126K ﹤0.01%
2,639
-251
-9% -$11.6K
ZIXI
9932
PUT
DELISTED
Zix Corporation
ZIXI
$126K ﹤0.01%
14,600
-5,500
-27% -$39.1K
MOTNU
9933
DELISTED
Motion Acquisition Corp. Unit
MOTNU
$126K ﹤0.01%
+11,867
New +$120K
BSM icon
9934
PUT
Black Stone Minerals
BSM
$3.17B
$125K ﹤0.01%
18,700
+8,600
+85% +$58.1K
CAPR icon
9935
CALL
Capricor Therapeutics
CAPR
$236M
$125K ﹤0.01%
36,400
-17,200
-32% -$74.6K
SNDL icon
9936
PUT
Sundial Growers
SNDL
$320M
$125K ﹤0.01%
+26,440
New +$91K
TLYS icon
9937
PUT
Tilly's
TLYS
$130M
$125K ﹤0.01%
+15,300
New +$116K
GHL
9938
PUT
DELISTED
Greenhill & Co., Inc.
GHL
$125K ﹤0.01%
10,300
-10,100
-50% -$130K
VNTR
9939
DELISTED
Venator Materials PLC
VNTR
$125K ﹤0.01%
+37,860
New +$90.3K
ACEVU
9940
DELISTED
ACE Convergence Acquisition Corp
ACEVU
$125K ﹤0.01%
11,474
-7,170
-38% -$73.4K
FCACU
9941
DELISTED
Falcon Capital Acquisition Corp. Unit
FCACU
$125K ﹤0.01%
11,669
+926
+9% +$9.6K
SPI
9942
PUT
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$125K ﹤0.01%
+15,900
New +$133K
FLY
9943
DELISTED
Fly Leasing Limited
FLY
$125K ﹤0.01%
+12,673
New +$98.9K
BLRX
9944
BioLineRX
BLRX
$12.1M
$124K ﹤0.01%
+1,233
New +$108K
DNOW icon
9945
CALL
DNOW Inc
DNOW
$2.6B
$124K ﹤0.01%
17,300
+6,000
+53% +$33.8K
JAKK icon
9946
Jakks Pacific
JAKK
$293M
$124K ﹤0.01%
24,861
+10,765
+76% +$51K
LXRX icon
9947
CALL
Lexicon Pharmaceuticals
LXRX
$1.11B
$124K ﹤0.01%
36,200
-15,300
-30% -$29.2K
NERV icon
9948
PUT
Minerva Neurosciences
NERV
$185M
$124K ﹤0.01%
6,613
+4,575
+224% +$115K
PTEN icon
9949
CALL
Patterson-UTI
PTEN
$3.76B
$123K ﹤0.01%
23,300
+100
+0.4% +$393
SNT
9950
Senstar Technologies
SNT
$46.7M
$123K ﹤0.01%
+31,759
New +$129K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.